WORCESTER, Mass.--(BUSINESS WIRE)--Agilux Laboratories today announced that it will be undergoing a significant space expansion to support growing demand for its pharmaceutical and biotech services, increasing the facility’s square footage more than two-fold to approximately 22,000 square feet. Founded in 2007, the company at launch provided non-GLP discovery bioanalytical services and has subsequently added In-Vitro ADMET, GLP bioanalytical and In-Vivo PK/PD services with additional service expansions planned.
